These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7357816)

  • 1. Clinical biostatistics. LI. Quantitative significance and statistical indexes for a contrast of two groups.
    Feinstein AR
    Clin Pharmacol Ther; 1980 Apr; 27(4):567-78. PubMed ID: 7357816
    [No Abstract]   [Full Text] [Related]  

  • 2. Comments on Brodsky's statistical methods for evaluating epidemiological results.
    Frome EL; Khare M
    Health Phys; 1980 Oct; 39(4):695-9. PubMed ID: 7429877
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical biostatistics. LVI. The t test and the basic ethos of parametric statistical inference (conclusion).
    Feinstein AR
    Clin Pharmacol Ther; 1981 Jul; 30(1):133-46. PubMed ID: 7237893
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical biostatistics. XLVII. Scientific standards vs. statistical associations and biologic logic in the analysis of causation.
    Feinstein AR
    Clin Pharmacol Ther; 1979 Apr; 25(4):481-92. PubMed ID: 428193
    [No Abstract]   [Full Text] [Related]  

  • 5. [The statistical inference of relative ratios].
    Huang ZN
    Zhonghua Yu Fang Yi Xue Za Zhi; 1986 May; 20(3):147-50. PubMed ID: 3769672
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical biostatistics. XXXVII. Demeaned errors, confidence games, nonplussed minuses, inefficient coefficients, and other statistical disruptions of scientific communication.
    Feinstein AR
    Clin Pharmacol Ther; 1976 Nov; 20(5):617-31. PubMed ID: 985637
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical biostatistics. XI. Sources of 'chronology bias' in cohort statistics.
    Feinstein AR
    Clin Pharmacol Ther; 1971; 12(5):864-79. PubMed ID: 5568260
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of mathematical methods in epidemiology. II. Empirical and theoretical distributions].
    Bezdenezhnykh IS; Burgasov IuA; Elkin II; Leont'eva LG; Tkacheva MN
    Boll Soc Ital Cardiol; 1970; 15(1):3-9. PubMed ID: 5494777
    [No Abstract]   [Full Text] [Related]  

  • 9. A method for tabulation and statistical evaluation of epidemiological malocclusion data.
    Solow B; Helm S
    Acta Odontol Scand; 1968 May; 26(1):63-88. PubMed ID: 5248107
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical biostatistics. XLIX. The basic data structures used in quantitative indexes.
    Feinstein AR
    Clin Pharmacol Ther; 1979 Oct; 26(4):525-34. PubMed ID: 487700
    [No Abstract]   [Full Text] [Related]  

  • 11. Papers from the International Society for Clinical Biostatistics. Sixth international meeting. September 1985.
    Stat Med; 1986; 5(5):399-553. PubMed ID: 3538260
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical biostatistics. X. Sources of 'transition bias' in cohort statistics.
    Feinstein AR
    Clin Pharmacol Ther; 1971; 12(4):704-21. PubMed ID: 5567812
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical biostatistics. XXVII. The derangements of the 'range of normal'.
    Feinstein AR
    Clin Pharmacol Ther; 1974 May; 15(5):528-40. PubMed ID: 4827470
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical biostatistics. II. Statistics versus science in design of experiments.
    Feinstein AR
    Clin Pharmacol Ther; 1970; 11(2):282-92. PubMed ID: 4906728
    [No Abstract]   [Full Text] [Related]  

  • 15. [Risks: definitions and computing methods (author's transl)].
    Lellouch J
    Rev Epidemiol Sante Publique; 1976; 24(3-4):201-10. PubMed ID: 1005851
    [No Abstract]   [Full Text] [Related]  

  • 16. Discussion for 'indexes of contrast and quantitative significance for comparisons of two groups'.
    Koch GG
    Stat Med; 1999 Oct; 18(19):2585-9; discussion 2591-2. PubMed ID: 10495456
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical biostatistics. XLIII. The architecture of cross-sectional reserach (conclusion).
    Feinstein AR
    Clin Pharmacol Ther; 1978 Apr; 23(4):481-93. PubMed ID: 305327
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect measures in biostatistics.
    Hilden J
    J Clin Epidemiol; 2003 Apr; 56(4):391-2; author reply 392-3. PubMed ID: 12767417
    [No Abstract]   [Full Text] [Related]  

  • 19. Synergy and antagonism in cause-effect relationships.
    Rothman KJ
    Am J Epidemiol; 1974 Jun; 99(6):385-8. PubMed ID: 4841816
    [No Abstract]   [Full Text] [Related]  

  • 20. Preface.
    Rolka HR
    Stat Med; 2011 Feb; 30(5):401-2. PubMed ID: 21312207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.